Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1154.8000 2.80 (0.24%)
NSE Jul 16, 2025 14:32 PM
Volume: 372.3K
 

logo
Aurobindo Pharma Ltd.
13 Feb 2024
1154.80
0.24%
buy
by BOB Capital Markets Ltd.
Target: 1100
BOB Capital Markets Ltd.
Q3 EBITDA/PAT surged 68%/90% YoY led by growth in US/EM revenue and ~700bps jump in operating margin
 
Aurobindo Pharma Ltd.'s price crossed above 30Day SMA today
More from Aurobindo Pharma Ltd.
Recommended
Market trades flat, Network18 Media & Investments' reports a net profit of Rs 148 crore in Q1
Trendlyne Marketwatch | 16 Jul 2025, 02:29PM
Five stocks to buy from analysts this week - July 15, 2025
The Baseline | 15 Jul 2025, 06:44PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020, 03:06PM